Cite
HARVARD Citation
Miller, A. et al. (2019). Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study. Journal of clinical neuroscience. pp. 229-231. [Online].